-The Deccan Chronicle   The Karnataka Forest Department continues to fight a losing battle with rogue elements in the tribal community who have caused irreparable ecological damage by setting fire to Nagarhole Tiger Reserve over the last one month. Though forest officials nabbed three persons in connection with forest fires in Metikuppe range on Tuesday, the accused were let off after protests from tribal and Dalit Sangarsha Samiti leaders early on Wednesday...

-The Times of India The Supreme Court on Tuesday criticized the Centre's "casual approach" during the hearing on appeals challenging a Delhi High Court verdict diluting Section 377 of the Indian Penal Code to decriminalize consensual gay sex between Consenting adults in private. The ministries of home affairs and health had opposed dilution of Section 377 before the HC but accepted the verdict and did not appeal against it in the apex...

-The Indian Express Gay rights activists today submitted in Supreme Court that criminalising homosexual acts is against constitutional values and that the law should not interfere when Consenting adults are involved. Naz Foundation, an NGO working for the welfare and rehabilitation of HIV infected people, contended that homosexuals face social ostracism with gay sex being declared as an offence. Appearing before a bench of justices G S Singhvi and S J Mukhopadhaya, the...

The government's decision to bust the price as well as monopoly of Bayer's anti-cancer drug, through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases.  More generic companies could invoke the compulsory licensing clause of the Indian Patents Act, following Monday's decision to allow Natco Pharma to sell...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...